{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:51:15Z","timestamp":1788954675518,"version":"build-2803163510"},"reference-count":22,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1265,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1111\/j.1742-1241.2011.02862.x","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T18:50:14Z","timestamp":1331837414000},"page":"394-398","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment"],"prefix":"10.1155","volume":"66","author":[{"given":"K.","family":"Homma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB1|cit1","first-page":"2705","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Havel","year":"2001"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-2275(20)41527-5","article-title":"Properties of an apoprote4in E-enriched fraction of triglyceride-rich lipoprotein isolated from huma plasma with a monoclonal antibody to apo B-100","volume":"33","author":"Campos","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-2275(20)30142-5","article-title":"Properties of triglyceride-rich and cholesterol rich lipoproteins in the remnant-like particle fraction of human blood plasma","volume":"43","author":"Campos","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/01.CIR.0000125278.58527.F3","article-title":"Elevated remnant-like particle cholesterol consentration: a characteristic feature of the atherogenic lipoprotein phenotype","volume":"109","author":"Trickler","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2005.12.013","article-title":"The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidixed LDL and remnant lipoproteins in plasma","volume":"367","author":"Nakajima","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.1991.22","article-title":"Lipid abnormalities in renal disease","volume":"39","author":"Appel","year":"1991","journal-title":"Kidney Int"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198208053070601","article-title":"Increased lipoprotein-remnant formation in chronic renal failure","volume":"307","author":"Neatel","year":"1982","journal-title":"New Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0021-9150(83)90165-X","article-title":"Accumulation of lipopprotein remnants in patients with chronic renal failure","volume":"46","author":"Ron","year":"1983","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000190133","article-title":"Remnant-like particle cholesterol may indivcate atherogenic risk in patients on chronic hemodialysis","volume":"76","author":"Oda","year":"1997","journal-title":"Nephron"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2007.03.015","article-title":"Remarkable increase of apolipoprotein B-48 level in diabetic patients with end-stage renal disease","volume":"197","author":"Hayashi","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB11|cit11","volume-title":"The Metabolic and Molecular Bases of Inherited disease","author":"Brunzell","year":"2001"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB12|cit12","first-page":"S260","article-title":"Homogeneous assay of serum LDL-cholesterol on an automated analyzer","volume":"43","author":"Nakamura","year":"1997","journal-title":"Clin Chem"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB13|cit13","first-page":"147","article-title":"Quantification of serum apolipoprotein A-I, A-II, B, C-II, C-III, and E by turbidimetric immunoassay: reference values, age-, sex-related differences","volume":"221","author":"Noma","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal antiapo B-100 and antiapo A-I immunoaffinity mixed gel","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB15|cit15","doi-asserted-by":"crossref","unstructured":"Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 2001 285 2486 2497","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB16|cit16","first-page":"79","article-title":"Predictors of atherosclerosis","volume":"53","author":"Homma","year":"2004","journal-title":"J Atheroscler Thromb"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.1984.94","article-title":"Pathogenic role of post-heparin lipases in lipid abnormalities in hemodialysis patients","volume":"25","author":"Chan","year":"1984","journal-title":"Kidney Int"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0021-9150(03)00011-X","article-title":"Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis","volume":"169","author":"Mekki","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB19|cit19","first-page":"10","article-title":"Effects of pravastatin on plasma lipids, apolipoproteins, Lp(a), remnant-like particle, cholesteryl ester transfer protein, and lecithin: cholesterol acyltransferase: 12-month study","volume":"4","author":"Nishiwaki","year":"1994","journal-title":"Nutr Met Cardiovasc Dis"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.39472.580984.AE","article-title":"Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomized controlled trials","volume":"336","author":"Strippoli","year":"2008","journal-title":"Br Med J"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.0000025586.89221.4B","article-title":"Elevated remnant-like particles in heterozygous familial hypercholesterolemia and response to statin treatment","volume":"106","author":"de Sauvage Nolting","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2011.02862.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.5551\/jat.4077","article-title":"Effects of low-dose simvastatin on the distribution of plasma cholesterol and oxidized low-density lipoprotein in three ultracentrifugally separated low-density lipoprotein subfractions: 12\u2003month, open-label trial","volume":"17","author":"Homma","year":"2010","journal-title":"J Athroscler Thromb"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02862.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02862.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:06:01Z","timestamp":1643349961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02862.x"}},"subtitle":["TG-rich lipoproteins in haemodialysis patients"],"short-title":[],"issued":{"date-parts":[[2012,3,15]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02862.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,15]]}}}